Fu Xiao-Long相关文献与解析，生知库 | 链接生命科学的每一步

Yang Zhao, Zhou Shu-Hua, Zhang Qi-Yue, Song Zhi-Chen, Liu Wen-Wen, Sun Yu, Wang Ming-Wei, Fu Xiao-Long, Zhu Kong-Kai, Guan Ying, Qi Jie-Yu, Wang Xiao-Hui, Sun Yu-Nan, Lu Yan, Ping Yu-Qi, Xi Yue-Tong, Teng Zhen-Xiao, Xu Lei, Xiao Peng, Xu Zhi-Gang, Xiong Wei, Qin Wei, Yang Wei, Yi Fan, Chai Ren-Jie, Yu Xiao, Sun Jin-Peng

GPCR/Calcium/cAMP

发表日期：2025

文献求助收藏

Clinical efficacies of different neoadjuvant therapies for non-small cell lung cancer

非小细胞肺癌不同新辅助疗法的临床疗效

期刊:Translational Oncology

影响因子:4.1

doi:10.1016/j.tranon.2024.102195

Tan, Xin-Chen; Song, Xin-Yun; Jiang, Meng-Qi; Wang, Neng-Yang; Liu, Jun; Yu, Wen; Zhang, Qin; Cai, Xu-Wei; Feng, Wen; Fu, Xiao-Long

Is postoperative radiotherapy effective in patients with completely resected pathologic stage IIIA(N2) non-small cell lung cancer? High-risk populations should consider it

对于病理分期为IIIA(N2)的非小细胞肺癌患者，术后放疗是否有效？高危人群应考虑接受放疗。

期刊:Clinical and Translational Radiation Oncology

影响因子:2.7

doi:10.1016/j.ctro.2024.100889

Zhang, Shu-Xian; Zhang, Chen-Chen; Hou, Run-Ping; Cai, Xu-Wei; Liu, Jun; Yu, Wen; Zhang, Qin; Guo, Jin-Dong; Wang, Chang-Lu; Li, Hong-Xuan; Zhu, Zheng-Fei; Fu, Xiao-Long; Feng, Wen

Who benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-dimensional model for candidate selection

I期肺腺癌患者中哪些人能从辅助化疗中获益？基于多维度的候选者筛选模型

期刊:Neoplasia

影响因子:7.7

doi:10.1016/j.neo.2024.100979

Jiang, Meng-Qi; Qian, Li-Qiang; Shen, Yu-Jia; Fu, Yuan-Yuan; Feng, Wen; Ding, Zheng-Ping; Han, Yu-Chen; Fu, Xiao-Long

The value of intervention with radiotherapy after first-line chemo-immunotherapy in locally advanced or metastatic esophageal squamous cell carcinoma: A multi-center retrospective study

局部晚期或转移性食管鳞状细胞癌一线化疗-免疫治疗后放射治疗的价值：一项多中心回顾性研究

期刊:Clinical and Translational Radiation Oncology

影响因子:2.7

doi:10.1016/j.ctro.2024.100818

Hu, Hui-Hui; Xu, Xin; Li, Xiao-Yang; Zeng, Ya; Li, Yue; Song, Xin-Yun; Fu, Xiao-Long; Ma, Xiu-Mei; Yu, Wen

PET-based radiomics visualizes tumor-infiltrating CD8 T cell exhaustion to optimize radiotherapy/immunotherapy combination in mouse models of lung cancer

基于PET的放射组学可可视化肿瘤浸润CD8 T细胞耗竭情况，从而优化肺癌小鼠模型中的放疗/免疫疗法联合治疗。

期刊:Biomarker Research

影响因子:11.5

doi:10.1186/s40364-023-00454-z

Zhang, Ying; Hu, Hui-Hui; Zhou, Shi-Hong; Xia, Wu-Yan; Zhang, Yan; Zhang, Jian-Ping; Fu, Xiao-Long; Yu, Wen

Enhancing Prediction for Tumor Pathologic Response to Neoadjuvant Immunochemotherapy in Locally Advanced Esophageal Cancer by Dynamic Parameters from Clinical Assessments

通过临床评估的动态参数提高对局部晚期食管癌新辅助免疫化疗肿瘤病理反应的预测能力

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers15174377

Song, Xin-Yun; Liu, Jun; Li, Hong-Xuan; Cai, Xu-Wei; Li, Zhi-Gang; Su, Yu-Chen; Li, Yue; Dong, Xiao-Huan; Yu, Wen; Fu, Xiao-Long

Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer

采用低分割同步增强调强放射治疗（IMRT）对不可切除的III期非小细胞肺癌进行剂量递增治疗

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-021-09099-3

Zhang, Qin; Cai, Xu-Wei; Feng, Wen; Yu, Wen; Fu, Xiao-Long

Individualized Fraction Regimen of SBRT Patients With Non-Small Cell Lung Cancer Based on Uncomplicated and Cancer-Free Control Probability

基于无并发症和无癌控制概率的非小细胞肺癌SBRT患者个体化分割方案

期刊:Technology in Cancer Research & Treatment

影响因子:2.8

doi:10.1177/15330338211011967

Feng, Ai-Hui; Wang, Hao; Chen, Hua; Gu, Heng-Le; Shao, Yan; Duan, Yan-Hua; Huang, Ying; Fu, Xiao-Long; Zhou, Tao; Xu, Zhi-Yong

Evaluation of IGRT-Induced Imaging Doses and Secondary Cancer Risk for SBRT Early Lung Cancer Patients In Silico Study

计算机模拟研究评估图像引导放射治疗（IGRT）诱导的成像剂量和立体定向放射治疗（SBRT）早期肺癌患者的继发性癌症风险

期刊:Technology in Cancer Research & Treatment

影响因子:2.8

doi:10.1177/15330338211016472

Duan, Yan-Hua; Gu, Heng-Le; Yang, Xiao-Hui; Chen, Hua; Wang, Hao; Shao, Yan; Li, Xiao-Yang; Feng, Ai-Hui; Ying, Yan-Chen; Fu, Xiao-Long; Ma, Kui; Zhou, Tao; Xu, Zhi-Yong

A force-sensitive adhesion GPCR is required for equilibrioception.

平衡感觉需要力敏粘附 GPCR

Clinical efficacies of different neoadjuvant therapies for non-small cell lung cancer

非小细胞肺癌不同新辅助疗法的临床疗效

Is postoperative radiotherapy effective in patients with completely resected pathologic stage IIIA(N2) non-small cell lung cancer? High-risk populations should consider it

对于病理分期为IIIA(N2)的非小细胞肺癌患者，术后放疗是否有效？高危人群应考虑接受放疗。

Who benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-dimensional model for candidate selection

I期肺腺癌患者中哪些人能从辅助化疗中获益？基于多维度的候选者筛选模型

The value of intervention with radiotherapy after first-line chemo-immunotherapy in locally advanced or metastatic esophageal squamous cell carcinoma: A multi-center retrospective study

局部晚期或转移性食管鳞状细胞癌一线化疗-免疫治疗后放射治疗的价值：一项多中心回顾性研究

PET-based radiomics visualizes tumor-infiltrating CD8 T cell exhaustion to optimize radiotherapy/immunotherapy combination in mouse models of lung cancer

基于PET的放射组学可可视化肿瘤浸润CD8 T细胞耗竭情况，从而优化肺癌小鼠模型中的放疗/免疫疗法联合治疗。

Enhancing Prediction for Tumor Pathologic Response to Neoadjuvant Immunochemotherapy in Locally Advanced Esophageal Cancer by Dynamic Parameters from Clinical Assessments

通过临床评估的动态参数提高对局部晚期食管癌新辅助免疫化疗肿瘤病理反应的预测能力

Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer

采用低分割同步增强调强放射治疗（IMRT）对不可切除的III期非小细胞肺癌进行剂量递增治疗

Individualized Fraction Regimen of SBRT Patients With Non-Small Cell Lung Cancer Based on Uncomplicated and Cancer-Free Control Probability

基于无并发症和无癌控制概率的非小细胞肺癌SBRT患者个体化分割方案

Evaluation of IGRT-Induced Imaging Doses and Secondary Cancer Risk for SBRT Early Lung Cancer Patients In Silico Study

计算机模拟研究评估图像引导放射治疗（IGRT）诱导的成像剂量和立体定向放射治疗（SBRT）早期肺癌患者的继发性癌症风险